Neurological Side Effects of Long-term Botulinum Toxin Use
Giovanna Silva Oliveira, Victoria Marques Santos, Carolyn Leal Carvalho, João Ronaldo Tavares de Vasconcellos Neto
Asian Journal of Biotechnology and Bioresource Technology · pp. 98–105 · Published 19 Jul 2025
10.9734/ajb2t/2025/v11i3246Abstract
Aims: To analyze and understand the neurological side effects associated with long-term use of botulinum toxin type A (BoNT-A), highlighting its implications on motor and sensory function in patients undergoing prolonged therapeutic application. Study Design: Qualitative exploratory-descriptive bibliographic review. Place and Duration of Study: The study was conducted using data collected from scientific literature indexed in PubMed, SciELO, and the Virtual Health Library (VHL), covering publications from 2013 to 2023. Methodology: A systematic search was performed using controlled descriptors such as Neurological Side Effects, Botulinum Toxin, Central Nervous System, and Peripheral Nervous System. Boolean operators “AND” and “OR” were applied to refine the search. Inclusion criteria focused on full-text articles in English, Portuguese, and Spanish that directly addressed the neurological impacts of BoNT-A. The review excluded duplicated materials, summaries, debates, and inaccessible content. The selected studies were analyzed through three axes: identification of neurological side effects, impacts on motor and sensory function, and mechanisms of influence on the central nervous system. Results: Findings indicated that BoNT-A is generally effective and safe for motor conditions such as spasticity and facial paralysis, though long-term use may result in mild to moderate adverse effects, including fatigue and muscle weakness. In chronic migraine treatment, BoNT-A showed significant improvement in pain frequency and quality of life. Potential retrograde transport of the toxin suggests central nervous system involvement. Statistical values were not derived as this was a literature-based review, but recurrent patterns across studies support the findings. Conclusion: Botulinum toxin type A remains a valuable therapeutic option; however, prolonged administration requires caution and individualized monitoring. Further research is necessary to fully understand its central mechanisms and to establish safer, optimized protocols for long-term neurological applications.
Cited by 0
No indexed citations yet.
Related research
- Effects of Botulinum Toxin (BoNT) and Factors on Weight Loss in Normotonic Pylorus (NP) and Hypotonic Pylorus (HP) Patients at Multivariate Level — shares topic coverage
- Botox Treatment: A Comprehensive Review — shares topic coverage
- Botulinum Toxin: A Friend or an Enemy? — shares topic coverage
- Ameliorative Histological Effects of Aqueous Neem Leaf Extract (Azadirachta indica) on Lead Induced Neurotoxicity of Lateral Geniculate Body of Adult Wistar Rats — shares topic coverage
- Mechanisms of Prooxidants in NeuroInflammatory Processes and Clinical Manifestations — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.